{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:16:27Z","timestamp":1793229387600,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY014685"],"award-info":[{"award-number":["R01 EY014685"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["P30 EY016665"],"award-info":[{"award-number":["P30 EY016665"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY025799"],"award-info":[{"award-number":["R01 EY025799"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Eye Institute"},{"name":"Research to Prevent Blindness Lew R. Wasserman Award"},{"name":"U.S. Department of Health & Human Services | NIH | National Eye Institute"},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL124120"],"award-info":[{"award-number":["R01 HL124120"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK114857"],"award-info":[{"award-number":["P30 DK114857"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary congenital glaucoma (PCG) is a severe disease characterized by developmental defects in the trabecular meshwork (TM) and Schlemm\u2019s canal (SC), comprising the conventional aqueous humor outflow pathway of the eye. Recently, heterozygous loss of function variants in <jats:italic>TEK<\/jats:italic> and <jats:italic>ANGPT1<\/jats:italic> or compound variants in <jats:italic>TEK<\/jats:italic>\/<jats:italic>SVEP1<\/jats:italic> were identified in children with PCG. Moreover, common variants in <jats:italic>ANGPT1<\/jats:italic>and <jats:italic>SVEP1<\/jats:italic> have been identified as risk alleles for primary open angle glaucoma (POAG) in GWAS studies. Here, we show tissue-specific deletion of <jats:italic>Angpt1<\/jats:italic> or <jats:italic>Svep1<\/jats:italic> from the TM causes PCG in mice with severe defects in the adjacent SC. Single-cell transcriptomic analysis of normal and glaucomatous <jats:italic>Angpt1<\/jats:italic> deficient eyes allowed us to identify distinct TM and SC cell populations and discover additional TM-SC signaling pathways. Furthermore, confirming the importance of angiopoietin signaling in SC, delivery of a recombinant ANGPT1-mimetic promotes developmental SC expansion in healthy and <jats:italic>Angpt1<\/jats:italic> deficient eyes, blunts intraocular pressure (IOP) elevation and RGC loss in a mouse model of PCG and lowers IOP in healthy adult mice. Our data highlight the central role of ANGPT1-TEK signaling and TM-SC crosstalk in IOP homeostasis and provide new candidates for SC-targeted glaucoma therapy.<\/jats:p>","DOI":"10.1038\/s41467-021-26346-0","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T19:27:17Z","timestamp":1634585237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Cellular crosstalk regulates the aqueous humor outflow pathway and provides new targets for glaucoma therapies"],"prefix":"10.1038","volume":"12","author":[{"given":"Benjamin R.","family":"Thomson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8891-2300","authenticated-orcid":false,"given":"Tuncer","family":"Onay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9788-6730","authenticated-orcid":false,"given":"Stuart W.","family":"Tompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol","family":"Misener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7227-2959","authenticated-orcid":false,"given":"Raj R.","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6994-9941","authenticated-orcid":false,"given":"Terri L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3706-5727","authenticated-orcid":false,"given":"Susan E.","family":"Quaggin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"26346_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley, H. A. & Broman, A. T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90, 262\u2013267 (2006).","journal-title":"Br. J. Ophthalmol."},{"key":"26346_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0014-4835(92)90121-8","volume":"55","author":"T Hamanaka","year":"1992","unstructured":"Hamanaka, T., Bill, A., Ichinohasama, R. & Ishida, T. Aspects of the development of Schlemm\u2019s canal. Exp. Eye Res. 55, 479\u2013488 (1992).","journal-title":"Exp. Eye Res."},{"key":"26346_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.exer.2014.06.011","volume":"125","author":"EL van der Merwe","year":"2014","unstructured":"van der Merwe, E. L. & Kidson, S. H. The three-dimensional organisation of the post-trabecular aqueous outflow pathway and limbal vasculature in the mouse. Exp. Eye Res. 125, 226\u2013235 (2014).","journal-title":"Exp. Eye Res."},{"key":"26346_CR4","doi-asserted-by":"publisher","first-page":"e1001912","DOI":"10.1371\/journal.pbio.1001912","volume":"12","author":"K Kizhatil","year":"2014","unstructured":"Kizhatil, K., Ryan, M., Marchant, J. K., Henrich, S. & John, S. W. M. Schlemm\u2019s canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental process. PLoS Biol. 12, e1001912 (2014).","journal-title":"PLoS Biol."},{"key":"26346_CR5","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1172\/JCI75395","volume":"124","author":"A Aspelund","year":"2014","unstructured":"Aspelund, A. et al. The Schlemm\u2019s canal is a VEGF-C\/VEGFR-3\u2013responsive lymphatic-like vessel. J. Clin. Invest. 124, 3975\u20133986 (2014).","journal-title":"J. Clin. Invest."},{"key":"26346_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.exer.2008.11.025","volume":"88","author":"O-Y Tektas","year":"2009","unstructured":"Tektas, O.-Y. & L\u00fctjen-Drecoll, E. Structural changes of the trabecular meshwork in different kinds of glaucoma. Exp. Eye Res. 88, 769\u2013775 (2009).","journal-title":"Exp. Eye Res."},{"key":"26346_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejpb.2015.04.029","volume":"95","author":"BM Braunger","year":"2015","unstructured":"Braunger, B. M., Fuchshofer, R. & Tamm, E. R. The aqueous humor outflow pathways in glaucoma: a unifying concept of disease mechanisms and causative treatment. Eur. J. Pharm. Biopharm. 95, 173\u2013181 (2015).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"26346_CR8","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ajo.2015.01.019","volume":"159","author":"SL Zagora","year":"2015","unstructured":"Zagora, S. L. et al. Primary congenital glaucoma outcomes: lessons from 23 years of follow-up. Am. J. Ophthalmol. 159, 788\u2013796.e782 (2015).","journal-title":"Am. J. Ophthalmol."},{"key":"26346_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass, M. A. et al. The ocular hypertension treatment study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120, 701\u2013713 (2002).","journal-title":"Arch. Ophthalmol."},{"key":"26346_CR10","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","volume":"108","author":"PR Lichter","year":"2001","unstructured":"Lichter, P. R. et al. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology 108, 1943\u20131953 (2001).","journal-title":"Ophthalmology"},{"key":"26346_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/aja.1002030109","volume":"203","author":"DJ Dumont","year":"1995","unstructured":"Dumont, D. J. et al. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn. 203, 80\u201392 (1995).","journal-title":"Dev. Dyn."},{"key":"26346_CR12","first-page":"1471","volume":"7","author":"DJ Dumont","year":"1992","unstructured":"Dumont, D. J., Yamaguchi, T. P., Conlon, R. A., Rossant, J. & Breitman, M. L. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 7, 1471\u20131480 (1992).","journal-title":"Oncogene"},{"key":"26346_CR13","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1172\/JCI85830","volume":"126","author":"T Souma","year":"2016","unstructured":"Souma, T. et al. Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity. J. Clin. Invest. 126, 2575\u20132587 (2016).","journal-title":"J. Clin. Invest."},{"key":"26346_CR14","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1172\/JCI95545","volume":"127","author":"BR Thomson","year":"2017","unstructured":"Thomson, B. R. et al. Angiopoietin-1 is required for Schlemm\u2019s canal development in mice and humans. J. Clin. Invest. 127, 4421\u20134436 (2017).","journal-title":"J. Clin. Invest."},{"key":"26346_CR15","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00439-017-1823-6","volume":"136","author":"M Kabra","year":"2017","unstructured":"Kabra, M. et al. Angiopoietin receptor TEK interacts with CYP1B1 in primary congenital glaucoma. Hum. Genet. 136, 941\u2013949 (2017).","journal-title":"Hum. Genet."},{"key":"26346_CR16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41588-018-0176-y","volume":"50","author":"S MacGregor","year":"2018","unstructured":"MacGregor, S. et al. Genome-wide association study of intraocular pressure uncovers new pathways to glaucoma. Nat. Genet. 50, 1067\u20131071 (2018).","journal-title":"Nat. Genet."},{"key":"26346_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41588-018-0126-8","volume":"50","author":"AP Khawaja","year":"2018","unstructured":"Khawaja, A. P. et al. Genome-wide analyses identify 68 new loci associated with intraocular pressure and improve risk prediction for primary open-angle glaucoma. Nat. Genet. 50, 778\u2013782 (2018).","journal-title":"Nat. Genet."},{"key":"26346_CR18","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1172\/JCI94668","volume":"127","author":"J Kim","year":"2017","unstructured":"Kim, J. et al. Impaired angiopoietin\/Tie2 signaling compromises Schlemm\u2019s canal integrity and induces glaucoma. J. Clin. Invest. 127, 3877\u20133896 (2017).","journal-title":"J. Clin. Invest."},{"key":"26346_CR19","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1167\/iovs.18-26349","volume":"60","author":"EA Thackaberry","year":"2019","unstructured":"Thackaberry, E. A. et al. Rapid development of glaucoma via ITV nonselective ANGPT 1\/2 antibody: a potential role for ANGPT\/TIE2 signaling in primate aqueous humor outflow. Invest. Ophthalmol. Vis. Sci. 60, 4097\u20134108 (2019).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"26346_CR20","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1161\/CIRCRESAHA.116.308825","volume":"120","author":"N Morooka","year":"2017","unstructured":"Morooka, N. et al. Polydom is an extracellular matrix protein involved in lymphatic vessel remodeling. Circ. Res. 120, 1276\u20131288 (2017).","journal-title":"Circ. Res."},{"key":"26346_CR21","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/CIRCRESAHA.116.308813","volume":"120","author":"T Karpanen","year":"2017","unstructured":"Karpanen, T. et al. An evolutionarily conserved role for Polydom\/Svep1 during lymphatic vessel formation. Circ. Res. 120, 1263\u20131275 (2017).","journal-title":"Circ. Res."},{"key":"26346_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.61.12.6","volume":"61","author":"TL Young","year":"2020","unstructured":"Young, T. L. et al. SVEP1 as a genetic modifier of TEK-related primary congenital glaucoma. Invest. Ophthalmol. Vis. Sci. 61, 6\u20136 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"26346_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20851-4","volume":"12","author":"P Gharahkhani","year":"2021","unstructured":"Gharahkhani, P. et al. Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries. Nat. Commun. 12, 1258 (2021).","journal-title":"Nat. Commun."},{"key":"26346_CR24","doi-asserted-by":"publisher","first-page":"e05521","DOI":"10.7554\/eLife.05521","volume":"4","author":"BO Zhou","year":"2015","unstructured":"Zhou, B. O., Ding, L. & Morrison, S. J. Hematopoietic stem and progenitor cells regulate the regeneration of their niche by secreting Angiopoietin-1. Elife 4, e05521 (2015).","journal-title":"Elife"},{"key":"26346_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15296","volume":"8","author":"DY Park","year":"2017","unstructured":"Park, D. Y. et al. Plastic roles of pericytes in the blood\u2013retinal barrier. Nat. Commun. 8, 15296 (2017).","journal-title":"Nat. Commun."},{"key":"26346_CR26","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/S0960-9822(07)00562-3","volume":"8","author":"PS Danielian","year":"1998","unstructured":"Danielian, P. S., Muccino, D., Rowitch, D. H., Michael, S. K. & McMahon, A. P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8, 1323\u2013S1322 (1998).","journal-title":"Curr. Biol."},{"key":"26346_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/dvg.20335","volume":"45","author":"MD Muzumdar","year":"2007","unstructured":"Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis 45, 593\u2013605 (2007).","journal-title":"Genesis"},{"key":"26346_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/0002-9394(89)90253-5","volume":"107","author":"BJ Tripathi","year":"1989","unstructured":"Tripathi, B. J. & Tripathi, R. C. Neural crest origin of human trabecular meshwork and its implications for the pathogenesis of glaucoma. Am. J. Ophthalmol. 107, 583\u2013590 (1989).","journal-title":"Am. J. Ophthalmol."},{"key":"26346_CR29","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1167\/iovs.05-0691","volume":"46","author":"PJ Gage","year":"2005","unstructured":"Gage, P. J., Rhoades, W., Prucka, S. K. & Hjalt, T. Fate maps of neural crest and mesoderm in the mammalian eye. Invest. Ophthalmol. Vis. Sci. 46, 4200\u20134208 (2005).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"26346_CR30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1600-0749.2006.00318.x","volume":"19","author":"K Bharti","year":"2006","unstructured":"Bharti, K., Nguyen, M.-T. T., Skuntz, S., Bertuzzi, S. & Arnheiter, H. The other pigment cell: specification and development of the pigmented epithelium of the vertebrate eye. Pigment. Cell Res. 19, 380\u2013394 (2006).","journal-title":"Pigment. Cell Res."},{"key":"26346_CR31","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1172\/JCI46322","volume":"121","author":"M Jeansson","year":"2011","unstructured":"Jeansson, M. et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J. Clin. Invest. 121, 2278\u20132289 (2011).","journal-title":"J. Clin. Invest."},{"key":"26346_CR32","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"EvanZ Macosko","year":"2015","unstructured":"Macosko, EvanZ. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202\u20131214 (2015).","journal-title":"Cell"},{"key":"26346_CR33","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1167\/iovs.08-3267","volume":"50","author":"FM Nadal-Nicola\u0301s","year":"2009","unstructured":"Nadal-Nicola\u0301s, F. M. et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in nai\u0308ve and optic nerve\u2013injured retinas. Invest. Ophthalmol. Vis. Sci. 50, 3860\u20133868 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"26346_CR34","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1172\/JCI75392","volume":"124","author":"D-Y Park","year":"2014","unstructured":"Park, D.-Y. et al. Lymphatic regulator PROX1 determines Schlemm\u2019s canal integrity and identity. J. Clin. Invest. 124, 3960\u20133974 (2014).","journal-title":"J. Clin. Invest."},{"key":"26346_CR35","doi-asserted-by":"publisher","first-page":"25615","DOI":"10.1074\/jbc.M112.355016","volume":"287","author":"R Sato-Nishiuchi","year":"2012","unstructured":"Sato-Nishiuchi, R. et al. Polydom\/SVEP1 is a ligand for integrin \u03b19\u03b21. J. Biol. Chem. 287, 25615\u201325630 (2012).","journal-title":"J. Biol. Chem."},{"key":"26346_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev-physiol-021115-105412","volume":"78","author":"CS Bartlett","year":"2016","unstructured":"Bartlett, C. S., Jeansson, M. & Quaggin, S. E. Vascular growth factors and glomerular disease. Annu. Rev. Physiol. 78, 437\u2013461 (2016).","journal-title":"Annu. Rev. Physiol."},{"key":"26346_CR37","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e1821 (2019).","journal-title":"Cell"},{"key":"26346_CR38","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1634\/stemcells.2004-0291","volume":"23","author":"M Sosnov\u00e1","year":"2005","unstructured":"Sosnov\u00e1, M., Bradl, M. & Forrester, J. V. CD34+ corneal stromal cells are bone marrow\u2013derived and express hemopoietic stem cell markers. Stem Cells 23, 507\u2013515 (2005).","journal-title":"Stem Cells"},{"key":"26346_CR39","doi-asserted-by":"publisher","first-page":"10339","DOI":"10.1073\/pnas.2001250117","volume":"117","author":"T van Zyl","year":"2020","unstructured":"van Zyl, T. et al. Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis. Proc. Natl Acad. Sci. USA 117, 10339\u201310349 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"26346_CR40","doi-asserted-by":"publisher","unstructured":"Lehmann, G. L. et al. Single-cell profiling reveals an endothelium-mediated immunomodulatory pathway in the eye choroid. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20190730 (2020).","DOI":"10.1084\/jem.20190730"},{"key":"26346_CR41","doi-asserted-by":"publisher","first-page":"5613","DOI":"10.1167\/iovs.13-11620","volume":"54","author":"KE Keller","year":"2013","unstructured":"Keller, K. E. et al. The Effects of Tenascin C Knockdown on Trabecular Meshwork Outflow Resistance. Invest. Ophthalmol. Vis. Sci. 54, 5613\u20135623 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"26346_CR42","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1742-4658.2004.04516.x","volume":"272","author":"Y Liang","year":"2005","unstructured":"Liang, Y. et al. Identification of a novel alternative splicing variant of RGS5 mRNA in human ocular tissues. FEBS J. 272, 791\u2013799 (2005).","journal-title":"FEBS J."},{"key":"26346_CR43","first-page":"241","volume":"18","author":"SH Paylakhi","year":"2012","unstructured":"Paylakhi, S. H. et al. Non-housekeeping genes expressed in human trabecular meshwork cell cultures. Mol. Vis. 18, 241\u2013254 (2012).","journal-title":"Mol. Vis."},{"key":"26346_CR44","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/bjophthalmol-2013-304593","volume":"98","author":"HS Dua","year":"2014","unstructured":"Dua, H. S. et al. The collagen matrix of the human trabecular meshwork is an extension of the novel pre-Descemet\u2019s layer (Dua\u2019s layer). Br. J. Ophthalmol. 98, 691 (2014).","journal-title":"Br. J. Ophthalmol."},{"key":"26346_CR45","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1167\/iovs.15-17127","volume":"57","author":"T Hamanaka","year":"2016","unstructured":"Hamanaka, T., Matsuda, A., Sakurai, T. & Kumasaka, T. Morphological abnormalities of Schlemm\u2019s canal in primary open-angle glaucoma from the aspect of aging. Invest. Ophthalmol. Vis. Sci. 57, 692\u2013706 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"26346_CR46","first-page":"729","volume":"41","author":"A Karali","year":"2000","unstructured":"Karali, A., Russell, P., Stefani, F. H. & Tamm, E. R. Localization of myocilin\/trabecular meshwork\u2013inducible glucocorticoid response protein in the human eye. Invest. Ophthalmol. Vis. Sci. 41, 729\u2013740 (2000).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"26346_CR47","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0161-6420(02)01042-4","volume":"109","author":"P Toti","year":"2002","unstructured":"Toti, P. et al. CD-34 stromal expression pattern in normal and altered human corneas. Ophthalmology 109, 1167\u20131171 (2002).","journal-title":"Ophthalmology"},{"key":"26346_CR48","doi-asserted-by":"publisher","unstructured":"Liu, P. et al. New soluble angiopoietin analog of Hepta-ANG1 prevents pathological vascular leakage. Biotechnol. Bioeng. https:\/\/doi.org\/10.1002\/bit.27580 (2020).","DOI":"10.1002\/bit.27580"},{"key":"26346_CR49","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1182\/blood-2008-08-174508","volume":"113","author":"I S\u00f6rensen","year":"2009","unstructured":"S\u00f6rensen, I., Adams, R. H. & Gossler, A. DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. Blood 113, 5680\u20135688 (2009).","journal-title":"Blood"},{"key":"26346_CR50","doi-asserted-by":"publisher","unstructured":"Carota, I. A. et al. Targeting VE-PTP phosphatase protects the kidney from diabetic injury. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20180009 (2019).","DOI":"10.1084\/jem.20180009"},{"key":"26346_CR51","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1215\/S1152851705000232","volume":"7","author":"G Bergers","year":"2005","unstructured":"Bergers, G. & Song, S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 7, 452\u2013464 (2005).","journal-title":"Neuro Oncol."},{"key":"26346_CR52","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.bbrc.2012.03.011","volume":"420","author":"K Sano","year":"2012","unstructured":"Sano, K. et al. Flt1 and Flk1 mediate regulation of intraocular pressure and their double heterozygosity causes the buphthalmia in mice. Biochem. Biophys. Res. Commun. 420, 422\u2013427 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"26346_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2005.02.008","volume":"81","author":"E L\u00fctjen-Drecoll","year":"2005","unstructured":"L\u00fctjen-Drecoll, E. Morphological changes in glaucomatous eyes and the role of TGF\u03b22 for the pathogenesis of the disease. Exp. Eye Res. 81, 1\u20134 (2005).","journal-title":"Exp. Eye Res."},{"key":"26346_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2156-2-18","volume":"2","author":"B Chang","year":"2001","unstructured":"Chang, B. et al. Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure. BMC Genet. 2, 18 (2001).","journal-title":"BMC Genet."},{"key":"26346_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.exer.2016.04.003","volume":"146","author":"EL van der Merwe","year":"2016","unstructured":"van der Merwe, E. L. & Kidson, S. H. Wholemount imaging reveals abnormalities of the aqueous outflow pathway and corneal vascularity in Foxc1 and Bmp4 heterozygous mice. Exp. Eye Res. 146, 293\u2013303 (2016).","journal-title":"Exp. Eye Res."},{"key":"26346_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/tvst.9.4.16","volume":"9","author":"BR Thomson","year":"2020","unstructured":"Thomson, B. R. et al. Angiopoietin-1 knockout mice as a genetic model of open-angle glaucoma. Transl. Vis. Sci. Technol. 9, 16\u201316 (2020).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"26346_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1042\/bj3520049","volume":"352","author":"D GILG\u00c8S","year":"2000","unstructured":"GILG\u00c8S, D. et al. Polydom: a secreted protein with pentraxin, complement control protein, epidermal growth factor and von Willebrand factor A domains. Biochem. J. 352, 49\u201359 (2000).","journal-title":"Biochem. J."},{"key":"26346_CR58","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jprot.2011.02.024","volume":"74","author":"WD Stamer","year":"2011","unstructured":"Stamer, W. D., Hoffman, E. A., Luther, J. M., Hachey, D. L. & Schey, K. L. Protein profile of exosomes from trabecular meshwork cells. J. Proteom. 74, 796\u2013804 (2011).","journal-title":"J. Proteom."},{"key":"26346_CR59","doi-asserted-by":"publisher","first-page":"6443","DOI":"10.1167\/iovs.11-7409","volume":"52","author":"UR Chowdhury","year":"2011","unstructured":"Chowdhury, U. R., Jea, S.-Y., Oh, D.-J., Rhee, D. J. & Fautsch, M. P. Expression profile of the matricellular protein osteopontin in primary open-angle glaucoma and the normal human eye. Invest. Ophthalmol. Vis. Sci. 52, 6443\u20136451 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"26346_CR60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12035-017-0734-9","volume":"55","author":"N Ruzafa","year":"2018","unstructured":"Ruzafa, N., Pereiro, X., Aspichueta, P., Araiz, J. & Vecino, E. The retina of osteopontin deficient mice in aging. Mol. Neurobiol. 55, 213\u2013221 (2018).","journal-title":"Mol. Neurobiol."},{"key":"26346_CR61","doi-asserted-by":"publisher","unstructured":"Patel, G. et al. Molecular taxonomy of human ocular outflow tissues defined by single-cell transcriptomics. Proc. Natl Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.2001896117 (2020).","DOI":"10.1073\/pnas.2001896117"},{"key":"26346_CR62","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0014-4835(71)90149-7","volume":"12","author":"A Bill","year":"1971","unstructured":"Bill, A. & Phillips, C. I. Uveoscleral drainage of aqueous humour in human eyes. Exp. Eye Res. 12, 275\u2013281 (1971).","journal-title":"Exp. Eye Res."},{"key":"26346_CR63","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/jbm.a.36376","volume":"106","author":"T Stack","year":"2018","unstructured":"Stack, T., Vahabikashi, A., Johnson, M. & Scott, E. Modulation of Schlemm\u2019s canal endothelial cell stiffness via latrunculin loaded block copolymer micelles. J. Biomed. Mater. Res A 106, 1771\u20131779 (2018).","journal-title":"J. Biomed. Mater. Res A"},{"key":"26346_CR64","doi-asserted-by":"publisher","unstructured":"Tanna, A. P. & Johnson, M. Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension. Ophthalmology https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.040 (2018).","DOI":"10.1016\/j.ophtha.2018.04.040"},{"key":"26346_CR65","doi-asserted-by":"publisher","first-page":"e48474","DOI":"10.7554\/eLife.48474","volume":"8","author":"BR Thomson","year":"2019","unstructured":"Thomson, B. R. et al. Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma. eLife 8, e48474 (2019).","journal-title":"eLife"},{"key":"26346_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/iovs.61.14.12","volume":"61","author":"G Li","year":"2020","unstructured":"Li, G. et al. A small molecule inhibitor of VE-PTP activates Tie2 in Schlemm\u2019s canal increasing outflow facility and reducing intraocular pressure. Invest. Ophthalmol. Vis. Sci. 61, 12\u201312 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"26346_CR67","doi-asserted-by":"publisher","unstructured":"Souma, T. et al. Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP. Proc. Natl Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1714446115 (2018).","DOI":"10.1073\/pnas.1714446115"},{"key":"26346_CR68","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ncb1715","volume":"10","author":"P Saharinen","year":"2008","unstructured":"Saharinen, P. et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat. Cell Biol. 10, 527\u2013537 (2008).","journal-title":"Nat. Cell Biol."},{"key":"26346_CR69","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ncb1714","volume":"10","author":"S Fukuhara","year":"2008","unstructured":"Fukuhara, S. et al. Differential function of Tie2 at cell\u2013cell contacts and cell\u2013substratum contacts regulated by angiopoietin-1. Nat. Cell Biol. 10, 513\u2013526 (2008).","journal-title":"Nat. Cell Biol."},{"key":"26346_CR70","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1182\/blood-2006-01-0141","volume":"107","author":"S B\u00e4umer","year":"2006","unstructured":"B\u00e4umer, S. et al. Vascular endothelial cell\u2013specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood 107, 4754\u20134762 (2006).","journal-title":"Blood"},{"key":"26346_CR71","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1083\/jcb.200811159","volume":"185","author":"M Winderlich","year":"2009","unstructured":"Winderlich, M. et al. VE-PTP controls blood vessel development by balancing Tie-2 activity. J. Cell Biol. 185, 657\u2013671 (2009).","journal-title":"J. Cell Biol."},{"key":"26346_CR72","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/nar\/gni051","volume":"33","author":"G Belteki","year":"2005","unstructured":"Belteki, G. et al. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res. 33, e51 (2005).","journal-title":"Nucleic Acids Res."},{"key":"26346_CR73","doi-asserted-by":"publisher","unstructured":"Thomson, B. R. et al. A lymphatic defect causes ocular hypertension and glaucoma in mice. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI77162 (2014).","DOI":"10.1172\/JCI77162"},{"key":"26346_CR74","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1167\/iovs.14-15691","volume":"56","author":"H Chen","year":"2015","unstructured":"Chen, H. et al. Progressive degeneration of retinal and superior collicular functions in mice with sustained ocular hypertensiondegeneration of visual functions in glaucoma. Invest. Ophthalmol. Vis. Sci. 56, 1971\u20131984 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"26346_CR75","doi-asserted-by":"crossref","unstructured":"Thomson, B. R. & Quaggin, S. E. in Lymphangiogenesis: Methods and Protocols (eds Oliver, G. & Kahn, M. L.) 153\u2013160 (Springer New York, 2018).","DOI":"10.1007\/978-1-4939-8712-2_10"},{"key":"26346_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02136-7","volume":"21","author":"P-L Germain","year":"2020","unstructured":"Germain, P.-L., Sonrel, A. & Robinson, M. D. pipeComp, a general framework for the evaluation of computational pipelines, reveals performant single cell RNA-seq preprocessing tools. Genome Biol. 21, 227 (2020).","journal-title":"Genome Biol."},{"key":"26346_CR77","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00180-010-0217-1","volume":"26","author":"A Henningsen","year":"2011","unstructured":"Henningsen, A. & Toomet, O. maxLik: A package for maximum likelihood estimation in R. Comput. Stat. 26, 443\u2013458 (2011).","journal-title":"Comput. Stat."},{"key":"26346_CR78","doi-asserted-by":"publisher","unstructured":"Thomson, B. R. et al. Cellular crosstalk regulates the aqueous humor outflow pathway and provides new targets for glaucoma therapies. GitHub https:\/\/doi.org\/10.5281\/zenodo.5172757 (2021).","DOI":"10.5281\/zenodo.5172757"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26346-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T16:17:32Z","timestamp":1669997852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26346-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["26346"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-26346-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,18]]},"assertion":[{"value":"11 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: S.E.Q. is an inventor of patents related to therapeutic targeting of the ANGPT-TEK pathway in ocular hypertension and glaucoma and owns stock in and is a director of Mannin Research. S.E.Q. also receives consulting fees from AstraZeneca, Janssen, the Lowy Medical Research Foundation, and Roche\/Genentech; is Chair of the External Scientific Advisory Board for AstraZeneca; and is a scientific advisor or member of AstraZeneca, Genentech\/Roche, the Karolinska CVRM Institute, the Lowy Medical Research Institute, Mannin, and Novartis. J.J. has applied for a patent related to the ANGPT1 mimetic compound described in the article. In addition, he is a scientific advisor for Mannin Research and QBioMed. T.L.Y. serves as a consultant to Aerpio Pharmaceuticals. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6072"}}